Aeterna Zentaris and Ceapro to merge in all-stock deal
Aeterna Zentaris and Ceapro to merge in all-stock deal
17.51MUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
CA0079754028
CUSIP
007975105
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
10.68
Dividend Share
-
Dividend Yield
-
Earnings Share
-2.31
Wall Street Target Price
15
EPS Estimate Current Year
0
EPS Estimate Next Year
0
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
2,374,000
Gross Profit TTM
5,170,000
EBITDA
-19,891,000
Profit Margin
0.00%
Return On Assets TTM
-29.96%
Return On Equity TTM
-81.71%
Revenue Per Share TTM
1.956
Qtly Revenue Growth YOY
-99.80%
Diluted Eps TTM
-2.31
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
7.3769
Price Book MRQ
0.9132
Enterprise Value Revenue
2
Enterprise Value EBITDA
3
83.00
0.94%278.17
0.92%96.18
0.73%84.91
0.45%625.30
0.00%167.31
0.00%190.00
0.00%41.72
-1.63%683.92
-1.54%439.45
-0.12%